Aquestive Therapeutics, Inc. (AQST) vs Delcath Systems, Inc. (DCTH)
A side-by-side comparison of Aquestive Therapeutics, Inc. and Delcath Systems, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AQST
Aquestive Therapeutics, Inc.
$4.60HealthcareDelayed quote: Oct 6, 2026, 3:40 PM EDT
DCTH
Delcath Systems, Inc.
$15.28HealthcareDelayed quote: Oct 6, 2026, 3:40 PM EDT
Total return — AQST vs DCTH
growth of $100 · dividends reinvested · last 8yAQST -71.5% (-14.5%/yr)DCTH -99.0% (-44.0%/yr)AQST compounded faster over this window
Log scale — wide-divergence pair
AQST DCTH
AQST vs DCTH: by the numbers
- •AQST is the larger company ($577M vs $527M market cap).
- •DCTH is profitable (0.56% net margin) while AQST runs a net loss (-144.63%).
- •DCTH grew revenue faster over the past five years (118.96% vs -0.58% CAGR).
Metrics side by side
Valuation
| Metric | AQST | DCTH |
|---|---|---|
| P/E ratio | N/A | 1175.38 |
| P/S ratio | 10.66 | 5.53 |
| P/B ratio | N/A | 4.35 |
| FCF yield | N/A | 3.32% |
Profitability
| Metric | AQST | DCTH |
|---|---|---|
| Gross margin | 67.04% | 87.05% |
| Operating margin | -156.36% | -1.90% |
| Net margin | -144.63% | 0.56% |
| ROE | N/A | 0.44% |
| ROIC | -45.62% | -0.81% |
Growth (annualized)
| Metric | AQST | DCTH |
|---|---|---|
| Revenue CAGR (5Y) | -0.58% | 118.96% |
| Total return CAGR (5Y) | 2.24% | 10.90% |
Frequently asked
- Which has grown faster, AQST or DCTH?
- Over the past five years, DCTH grew revenue faster — AQST at a -0.58% CAGR versus DCTH at 118.96%.
- Is AQST or DCTH more profitable?
- DCTH runs the higher net margin — AQST at -144.63% versus DCTH at 0.56%.
- How have AQST and DCTH total returns compared?
- Over the past 5 years, AQST delivered 2.24% and DCTH delivered 10.90% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Delcath Systems P/E ratioAquestive Therapeutics ROEDelcath Systems ROEAquestive Therapeutics operating marginDelcath Systems operating marginAquestive Therapeutics revenue growthDelcath Systems revenue growthAquestive Therapeutics free cash flowDelcath Systems free cash flow
Aquestive Therapeutics & Delcath Systems appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.